| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Feb 2026 | 29 Jan 2026 |
| Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2025 along with Limited Review Report issued by the Statutory Auditors of the Company thereon. Outcome of the Board Meeting held on Friday, 6th February 2026. (As Per BSE Announcement Dated on: 06/02/2026) | ||
| Board Meeting | 14 Nov 2025 | 7 Nov 2025 |
| Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2025 along with Limited Review Report of the Statutory Auditors of the Company thereon. Outcome of the Board Meeting held on Friday, 14th November 2025. (As per BSE Announcement dated on: 14.11.2025) | ||
| Board Meeting | 13 Aug 2025 | 7 Aug 2025 |
| Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of The Company for the Quarter Ended June 30 2025. Unaudited Financial Results and Limited Review for the quarter ended June 30, 2025 (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 28 May 2025 | 23 May 2025 |
| Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the Audited standalone and consolidated financial results of the Company for the quarter and year ended 31st March 2025. Outcome of Board Meeting held on Wednesday, 28th May 2025 Pursuant to provision of Regulation 30 and 33 and otjer applicable provision of SEBI(LODR) 2015 to consider, approved and taken on record the matter mentioned in the attachment. (As Per BSE Announcement dated on 28.05.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
